The chairman of an outside committee of medical experts that advises the Food and Drug Administration on drug-safety issues said Friday the agency's own drug-safety oversight board needed to be more open and transparent. The chairman of the committee recommended that the FDA add new members to its oversight board.
You can ping this entry by using http://www.saundersblog.com/cgi-bin/mt/mt-tb.cgi/162 .